Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6419)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song DS, Nam SW, Bae SH, Kim JD, Jang JW, Song MJ, Lee SW, Kim HY, Lee YJ, Chun HJ, You YK, Choi JY, Yoon SK. Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma. World J Gastroenterol 2015; 21(8): 2395-2404 [PMID: 25741147 DOI: 10.3748/wjg.v21.i8.2395] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i8/2395.htm |
| Number | Citing Articles |
| 1 |
Yifan Tong, Zheyong Li, Yuelong Liang, Hong Yu, Xiao Liang, Hui Liu, Xiujun Cai. Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis. Oncotarget 2017; 8(16): 26671 doi: 10.18632/oncotarget.15793
|
| 2 |
Huan Chen, Jing Chen, Huixin Yuan, Xiuhui Li, Weihua Li. Hypoxia‑inducible factor‑1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma (Review). Oncology Letters 2022; 24(2) doi: 10.3892/ol.2022.13404
|
| 3 |
Y. Kishi, S. Nara, M. Esaki, N. Hiraoka, K. Shimada. Salvage hepatectomy for local recurrence of hepatocellular carcinomas offers survival comparable to that of matched patients who undergo primary hepatectomies. European Journal of Surgical Oncology (EJSO) 2017; 43(6): 1076 doi: 10.1016/j.ejso.2017.03.021
|
| 4 |
Hongjun Yuan, Xin Li, Jing Tang, Min Zhou, Fengyong Liu. Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization–photothermal ablation treatment of hepatocellular carcinoma in rats. Cancer Imaging 2019; 19(1) doi: 10.1186/s40644-019-0257-x
|
| 5 |
QIANQIAN ZHANG, SHIXING ZHAO, XIAOLI PANG, BAORONG CHI. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma. Oncology Reports 2016; 35(3): 1831 doi: 10.3892/or.2015.4491
|
| 6 |
Lei Xu, Lin Chen, Wei Zhang. Neoadjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2021; 13(12): 1550-1566 doi: 10.4240/wjgs.v13.i12.1550
|
| 7 |
Wen-Sheng Tzeng, Wei-Lin Teng, Pao-Hsien Huang, Tzu-Ching Lin, Feng-Lin Yen, Yow-Ling Shiue. Pterostilbene Nanoparticles Downregulate Hypoxia-Inducible Factors in Hepatoma Cells Under Hypoxic Conditions. International Journal of Nanomedicine 2021; : 867 doi: 10.2147/IJN.S282172
|
| 8 |
Ke Yang, Xiao-Ming Zhang, Lin Yang, Hao Xu, Juan Peng. Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(20): 4835-4847 doi: 10.3748/wjg.v22.i20.4835
|
| 9 |
Yung-Yeh Su, Chia-Chen Li, Yih-Jyh Lin, Chiun Hsu. Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives. Seminars in Liver Disease 2021; 41(03): 263 doi: 10.1055/s-0041-1730949
|
| 10 |
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations. Journal of Clinical and Experimental Hepatology 2024; 14(1): 101269 doi: 10.1016/j.jceh.2023.08.005
|
| 11 |
H. Abdella, M. K. Shaker, Iman Fawzy Montasser, M. Sobhi, H. Aly, A. Sayed, S. Saleh, A. El Dorry. Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis. Indian Journal of Gastroenterology 2018; 37(2): 127 doi: 10.1007/s12664-018-0830-4
|
| 12 |
Herman P. Marquez, Amar Karalli, Holger Haubenreisser, Rishi P. Mathew, Hatem Alkadhi, Torkel B. Brismar, Thomas Henzler, Michael A. Fischer. Computed tomography perfusion imaging for monitoring transarterial chemoembolization of hepatocellular carcinoma. European Journal of Radiology 2017; 91: 160 doi: 10.1016/j.ejrad.2017.03.014
|
| 13 |
Zhaonan Li, DeChao Jiao, Guangyan Si, Xinwei Han, Wenguang Zhang, Yahua Li, Xueliang Zhou, Juanfang Liu, Jin Li, Zaoqu Liu. Making timely remedial measures after TACE based on the results of cone-beam CT liver perfusion. International Journal of Hyperthermia 2021; 38(1): 428 doi: 10.1080/02656736.2021.1895331
|
| 14 |
Peng-Hui Hu, Lan-Hong Pan, Patrick Ting-Yat Wong, Wen-Hui Chen, Yan-Qing Yang, Hong Wang, Jun-Jian Xiang, Meng Xu. <sup>125</sup>I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(21): 5033-5041 doi: 10.3748/wjg.v22.i21.5033
|
| 15 |
Jie-Yu Kong, Shu-Mei Li, Hai-Yan Fan, Lan Zhang, Hui-Jin Zhao, Sheng-Mian Li. Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma. Medicine 2018; 97(33): e11872 doi: 10.1097/MD.0000000000011872
|
| 16 |
Wei Zhang, An-Hui Xu, Wei Wang, Yan-Hui Wu, Qian-Ling Sun, Chang Shu. Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantation. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6265-1
|